A Phase 2b, Extension Study to Determine the Long-term Safety of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2018
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions
- Acronyms Hubble zoom
- Sponsors Takeda
- 13 Mar 2018 Planned initiation date changed from 1 May 2018 to 22 May 2018.
- 09 Jan 2018 Planned initiation date changed from 10 Nov 2017 to 1 May 2018.
- 27 Jun 2017 New trial record